FGFR3 and non-small cell lung carcinoma: Furthermore, some studies have suggested distinct clinicopathological characteristics of FGFR3-fused NSCLC including more frequent association with smoking, significantly larger tumor size, and more frequent poor differentiation than those without FGFR fusions [13].